Impel Pharmaceuticals

📍 Seattle, United States🗓 Founded 2008👥 137 employees💰 Last funded May 2017
Pharmaceutical Manufacturing🌐 impelpharma.com
Website LinkedIn
Impel Pharmaceuticals is focused on developing and providing transformative therapies for people suffering from diseases with high unmet needs across various disease areas in addition to the central nervous system (CNS), through the pioneering of an optimized approach to drug delivery. We offer and develop treatments that pair the Company’s proprietary Precision Olfactory Delivery (POD®) technology with well-established therapeutics.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Impel Pharmaceuticals?
Impel Pharmaceuticals has 2 investors on record on gritt.io and 2 late-stage investors.
When did Impel Pharmaceuticals last raise funding?
The most recent investment in Impel Pharmaceuticals recorded on gritt.io was in May 2017.
When was Impel Pharmaceuticals founded?
Impel Pharmaceuticals was founded in 2008.
What industry is Impel Pharmaceuticals in?
Impel Pharmaceuticals operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Impel Pharmaceuticals based?
Impel Pharmaceuticals is headquartered in Seattle, United States.